Cellectar Biosciences (CLRB) SEC Filings & 10K Form

$3.07
-0.17 (-5.25%)
(As of 04:00 PM ET)

Recent Cellectar Biosciences SEC Filings

DateFilerForm TypeView
04/26/2024
3:58 PM
Cellectar Biosciences (Filer)
Form DEF 14A
04/26/2024
3:59 PM
Cellectar Biosciences (Filer)
Form DEFA14A
04/25/2024
7:01 PM
Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
Form SC 13G/A
03/27/2024
5:45 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
5:30 AM
Cellectar Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
7:31 PM
Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
Form SC 13G/A
02/14/2024
2:23 PM
Cellectar Biosciences (Subject)
LYTTON LAURENCE W (Filed by)
Form SC 13G/A
02/07/2024
5:58 PM
Cellectar Biosciences (Subject)
HIRSCHMAN ORIN (Filed by)
Form SC 13G/A
02/02/2024
5:03 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
7:00 AM
ADAR1 Partners, LP (Filed by)
Cellectar Biosciences (Subject)
Form SC 13G
01/09/2024
5:02 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
7:04 PM
CARUSO JAMES V (Reporting)
Cellectar Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
7:04 PM
Cellectar Biosciences (Issuer)
Longcor Jarrod (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
7:05 PM
Cellectar Biosciences (Issuer)
Shustov Andrei (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
7:07 PM
Cellectar Biosciences (Issuer)
Kolean Chad J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
7:09 PM
Cellectar Biosciences (Issuer)
Lea Darrell Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
4:15 PM
Cellectar Biosciences (Subject)
LYTTON LAURENCE W (Filed by)
Form SC 13G
12/05/2023
5:01 AM
Cellectar Biosciences (Subject)
HIRSCHMAN ORIN (Filed by)
Form SC 13G
11/29/2023
3:31 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
5:30 AM
Cellectar Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
6:45 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2023
11:15 PM
Cellectar Biosciences (Filer)
Form EFFECT
10/27/2023
3:40 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2023
3:54 PM
Cellectar Biosciences (Filer)
Form S-3/A
10/05/2023
3:45 PM
Cellectar Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/02/2023
3:40 PM
Cellectar Biosciences (Filer)
Form DEF 14A
09/22/2023
3:40 PM
Cellectar Biosciences (Filer)
Form PRE 14A
09/22/2023
3:30 PM
Cellectar Biosciences (Filer)
Form D
Notice of Exempt Offering of Securities 
09/08/2023
4:17 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2023
3:30 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
7:45 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
7:30 AM
Cellectar Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/29/2023
3:31 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2023
5:03 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2023
5:27 PM
Cellectar Biosciences (Issuer)
Swirsky Douglas J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
5:24 PM
Cellectar Biosciences (Issuer)
Chanan-Khan Asher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
5:24 PM
Cellectar Biosciences (Issuer)
DRISCOLL FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
5:25 PM
Cellectar Biosciences (Issuer)
Loren Stefan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
5:26 PM
Cellectar Biosciences (Issuer)
NEIS JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
5:08 AM
Cellectar Biosciences (Filer)
Form 8-K/A
06/20/2023
5:09 AM
Cellectar Biosciences (Filer)
Form DEFA14A
The Crypto 9-5 Escape Plan (Ad)

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide
06/14/2023
3:25 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2023
3:27 PM
Cellectar Biosciences (Filer)
Form DEFA14A
06/13/2023
3:30 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CLRB) was last updated on 5/10/2024 by MarketBeat.com Staff

From Our Partners